Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report

doi:10.12998/wjcc.v8.i3.517

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7165)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

318

WORD

258

HTML

3575

Figures (1-1)

315

Sum=4466

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

324

Download

836

Sum=1160

Publishing Process of This Article

Item

Count

Browse

519

Download

1006

Sum=1525

Feb 6, 2020 (publication date) through Jan 9, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 6, 2020; 8(3): 517-521
Published online Feb 6, 2020. doi: 10.12998/wjcc.v8.i3.517

Open in New Tab Full Size Figure Download Figure

Figure 1 Positron emission tomography scan. A: November 2018: positron emission tomography scan shows a 4-cm lesion in the right subclavicular region, infiltrating the chest wall and extending to the subclavian vessels; B: Positron emission tomography scan shows complete response after neoadjuvant treatment.

Citation: Palleschi M, Maltoni R, Barzotti E, Melegari E, Curcio A, Cecconetto L, Sarti S, Manunta S, Rocca A. Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report. World J Clin Cases 2020; 8(3): 517-521
URL: https://www.wjgnet.com/2307-8960/full/v8/i3/517.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i3.517